Leticia Fernández-Friera
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Leticia Fernández-Friera has a total of 556 co-authors. Here are the top co-authors by number of shared publications:
- Valentin Fuster
Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain
44 shared publications - Borja Ibanez
Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain
38 shared publications Javier Sanz
Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain; Icahn School of Medicine at Mount Sinai, New York, New York
25 shared publications- Rodrigo Fernández-Jiménez
Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain
21 shared publications - Antonio Fernández-Ortiz
Cardiovascular Institute, Hospital Clínico San Carlos, 28040 Madrid, Spain
17 shared publications - Gonzalo Pizarro
Affiliations Centro de Investigación Biomédica en Red (CIBER)-CV, Madrid, Spain, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain
16 shared publications
Latest Publications
- 20 May 2025
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 145 (10) , 2474-2483.e4
Residual Inflammation in Patients with Psoriasis Treated with Biologic Therapy: Findings from 3 Prospective Observational Cohorts
- 20 May 2025
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 145 (10) , 2474-2483.e4
Residual Inflammation in Patients with Psoriasis Treated with Biologic Therapy: Findings from 3 Prospective Observational Cohorts
- Open Access
- 9 March 2025
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 38 (1) , 2459302
Cardiovascular disease in women with early-onset preeclampsia: a matched case-control study
To compare the risk of cardiovascular disease and the occurrence of cardiovascular events in the mid-long term after delivery, between women with and without a history of early-onset preeclampsia. A prospective case-control study has been conducted in Hospital Universitario 12 de Octubre, Madrid. 50 women with early-onset preeclampsia (diagnosed < 34 + 0 weeks) who delivered between 2008 and 2017 and a matched group (by age, parity, pregestational body mass index and date of delivery) of 50 women with uncomplicated pregnancies were recruited. In them, a 1-day visit for cardiovascular assessment was performed 3-12 years after delivery, consisting of the completion of blood and urine tests including oxidative stress analysis, vascular ultrasound to assess subclinical atherosclerosis and 24-hour blood pressure monitoring. Furthermore, Framingham10 and Framingham30 scales of cardiovascular disease risk were applied. Univariate analysis was used for comparisons, and the Kaplan-Meier method was performed to estimate their survival time until the development of a cardiovascular disease event (chronic hypertension, renal disease, myocardial infarction, thromboembolism and cerebrovascular disease). Patients were evaluated at a median of 7.5 years (interquartile range, 6.5-9) after delivery. Women with a history of early-onset preeclampsia vs controls showed significantly lower levels of hemoglobin (12.9 vs 13.7 g/dL), hematocrit (38.9 vs 40.8%), prothrombin activity (93.1 vs 99.8%), IgA (223.5 vs 279.9 mg/dL) and C3 factor (101.0 vs 110.5 mg/dL) and prolongated prothrombin time (12.4 vs 11.6 s). Early-onset preeclampsia cases showed worse blood pressure control, with higher percentages of over-limit systolic blood pressure (17.9 vs. 11.2%, p < 0.01) and diastolic blood pressure (28.1 vs. 18.7%, p < 0.01) readings in 24 h. There were no significant differences in the vascular ultrasound studies as well as in the estimated cardiovascular risk obtained with the Framingham scales. At the visit time, a cardiovascular event was present in 44% women with history of early-onset preeclampsia vs 10% in the control group (p < 0.01). The most common event was chronic hypertension, with a relative risk of 4.7 (95% confidence interval 1.7-13.0) for the early-onset preeclampsia group. Women with a history of early-onset preeclampsia, compared to their matched controls, showed a greater risk of cardiovascular disease mainly at the expense of a 4.7-fold risk of developing chronic hypertension, with a median follow-up of 7.5 years after delivery.
- 9 March 2025
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 38 (1) , 2459302
Open AccessCardiovascular disease in women with early-onset preeclampsia: a matched case-control study
To compare the risk of cardiovascular disease and the occurrence of cardiovascular events in the mid-long term after delivery, between women with and without a history of early-onset preeclampsia. A prospective case-control study has been conducted in Hospital Universitario 12 de Octubre, Madrid. 50 women with early-onset preeclampsia (diagnosed < 34 + 0 weeks) who delivered between 2008 and 2017 and a matched group (by age, parity, pregestational body mass index and date of delivery) of 50 women with uncomplicated pregnancies were recruited. In them, a 1-day visit for cardiovascular assessment was performed 3-12 years after delivery, consisting of the completion of blood and urine tests including oxidative stress analysis, vascular ultrasound to assess subclinical atherosclerosis and 24-hour blood pressure monitoring. Furthermore, Framingham10 and Framingham30 scales of cardiovascular disease risk were applied. Univariate analysis was used for comparisons, and the Kaplan-Meier method was performed to estimate their survival time until the development of a cardiovascular disease event (chronic hypertension, renal disease, myocardial infarction, thromboembolism and cerebrovascular disease). Patients were evaluated at a median of 7.5 years (interquartile range, 6.5-9) after delivery. Women with a history of early-onset preeclampsia vs controls showed significantly lower levels of hemoglobin (12.9 vs 13.7 g/dL), hematocrit (38.9 vs 40.8%), prothrombin activity (93.1 vs 99.8%), IgA (223.5 vs 279.9 mg/dL) and C3 factor (101.0 vs 110.5 mg/dL) and prolongated prothrombin time (12.4 vs 11.6 s). Early-onset preeclampsia cases showed worse blood pressure control, with higher percentages of over-limit systolic blood pressure (17.9 vs. 11.2%, p < 0.01) and diastolic blood pressure (28.1 vs. 18.7%, p < 0.01) readings in 24 h. There were no significant differences in the vascular ultrasound studies as well as in the estimated cardiovascular risk obtained with the Framingham scales. At the visit time, a cardiovascular event was present in 44% women with history of early-onset preeclampsia vs 10% in the control group (p < 0.01). The most common event was chronic hypertension, with a relative risk of 4.7 (95% confidence interval 1.7-13.0) for the early-onset preeclampsia group. Women with a history of early-onset preeclampsia, compared to their matched controls, showed a greater risk of cardiovascular disease mainly at the expense of a 4.7-fold risk of developing chronic hypertension, with a median follow-up of 7.5 years after delivery.
- Open Access
- 11 September 2024
- Published by Elsevier in JACC: Cardiovascular Imaging
- Vol. 18 (1) , 48-58
Coronary Microvascular Function in Asymptomatic Middle-Aged Individuals With Cardiometabolic Risk Factors
- 11 September 2024
- Published by Elsevier in JACC: Cardiovascular Imaging
- Vol. 18 (1) , 48-58
Open AccessCoronary Microvascular Function in Asymptomatic Middle-Aged Individuals With Cardiometabolic Risk Factors
- 28 November 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (5) , 1075-1087.e2
Association of the Complement System with Subclinical Atherosclerosis in Psoriasis: Findings from an Observational Cohort Study
- 28 November 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (5) , 1075-1087.e2
Association of the Complement System with Subclinical Atherosclerosis in Psoriasis: Findings from an Observational Cohort Study
- 11 August 2022
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 17 (2) , e7-e8
Intravascular pulmonary myxoid sarcoma incidentally detected by computed tomography
- 11 August 2022
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 17 (2) , e7-e8
Intravascular pulmonary myxoid sarcoma incidentally detected by computed tomography
- Open Access
- 3 June 2022
- Published by Elsevier in Nefrología
- Vol. 43 (3) , 269-280
Salud cardiovascular y renal en la mujer: la preeclampsia como marcador de riesgo
- 3 June 2022
- Published by Elsevier in Nefrología
- Vol. 43 (3) , 269-280
Open AccessSalud cardiovascular y renal en la mujer: la preeclampsia como marcador de riesgo
- 1 January 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 142 (1) , 88-96
Subclinical Liver Disease Is Associated with Subclinical Atherosclerosis in Psoriasis: Results from Two Observational Studies
- 1 January 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 142 (1) , 88-96
Subclinical Liver Disease Is Associated with Subclinical Atherosclerosis in Psoriasis: Results from Two Observational Studies
- Open Access
- 30 August 2021
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 5 (11) , ytab323
Case report of an acute coronary syndrome in a patient with artery coronary fistulae
Background: Coronary artery fistulae are rare vascular anomalies. Although they are usually asymptomatic, the presence of symptoms might present a challenge in the diagnostic and therapeutic management. Case summary: We present a patient with chest pain whose initial tests were normal, but coronary artery fistulae were found. Single-photon emission computed tomography test showed ischaemia due to coronary artery fistulae and cardiac computed tomography helped in the planning of the percutaneous closure. Discussion: CCT is emerging as an optimal non-invasive tool to characterise the morphology and course of coronary artery fistulae and may be essential for its accurate diagnosis and planning for percutaneous closure.
- 30 August 2021
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 5 (11) , ytab323
Open AccessCase report of an acute coronary syndrome in a patient with artery coronary fistulae
Background: Coronary artery fistulae are rare vascular anomalies. Although they are usually asymptomatic, the presence of symptoms might present a challenge in the diagnostic and therapeutic management. Case summary: We present a patient with chest pain whose initial tests were normal, but coronary artery fistulae were found. Single-photon emission computed tomography test showed ischaemia due to coronary artery fistulae and cardiac computed tomography helped in the planning of the percutaneous closure. Discussion: CCT is emerging as an optimal non-invasive tool to characterise the morphology and course of coronary artery fistulae and may be essential for its accurate diagnosis and planning for percutaneous closure.
- Open Access
- 1 January 2021
- Published by Fortune Journals in Archives of Clinical and Medical Case Reports
- Vol. 05 (01) , 75-83
Cardiac Magnetic Resonance in times of COVID-19: A Disease with Many Cardiac Faces
Although cardiac magnetic resonance (CMR) may proof useful in the diagnosis of myocardial injury triggered by COVID-19, limited experience has yet been published. We report several cases presenting its utility at various COVID-19 disease stages in diagnosing different cardiac manifestations. The current COVID-19 crisis will undoubtedly transform CMR imaging Units.
- 1 January 2021
- Published by Fortune Journals in Archives of Clinical and Medical Case Reports
- Vol. 05 (01) , 75-83
Open AccessCardiac Magnetic Resonance in times of COVID-19: A Disease with Many Cardiac Faces
Although cardiac magnetic resonance (CMR) may proof useful in the diagnosis of myocardial injury triggered by COVID-19, limited experience has yet been published. We report several cases presenting its utility at various COVID-19 disease stages in diagnosing different cardiac manifestations. The current COVID-19 crisis will undoubtedly transform CMR imaging Units.